Indeed, preclinical studies indicate that approximately half of non-small cell lung cancer (NSCLC) cell lines are intrinsically resistant to TRAIL-induced cell death, and several mechanisms underlying TRAIL-resistance in NSCLC have been suggested [15]. Here, TNFSF10 is linked to non-small cell lung carcinoma.